Member Info for B2HS2L

Chris, - One of those officers is Antonio Argenio - Sales Director - B2B Private Healthcare
He has been liking some good opportunities on LinkedIn.

Chris what other appointments can they be short of presently, - or are you referring to some officers being replaced?

Like this post if you don't think we will be interested in NASDAQ from now on.

Despite GM saying no NASDAQ listing being sought, I believe we are into a new period, and they may change their tune.
Like this post if you think this is the situation, - Like the next one if you don't think we will be interested in NASDAQ from now on. If you think our needs can be met by buying a US company or merging with one or agreeing joint programs, please let us know.

Thanks ChriToffer, - more food for thought.

In the video: https://www.youtube.com/watch?v=n0KhQd_z1KY
@ 1:50:25 - he states whilst discussing DA, (inspecting his notes)
"David's background - he says he has a degree in Microbiology".

To be fair James says "I am very happy to be appointing him to take over from Graham" later.

++++

Just prior to this statement he stated that Amryt have recently listed on Nasdaq, so if they wanted a business manager familiar with the pro's and con's and contacts of actually listing, there is no one better placed than David.

GM may have stated earlier they have no plans for Nasdaq listing, but that doesn't mean that the next board meeting agenda does not contain Nasdaq listing - how to - with DA's initials beside that item. (my speculation)

Yesterday I provided some research containing links concerning business opportunity and threats to David Allmond.
I'm sure he will delegate review of research to others, if you are inclined to provide more research.
From what I can see on that video, I think he could be in a lonely place right now.

Tanks Malaria :)

So provide the link if its so awesome.
Not scanning twitter all morning

Poidster -
I agree it was odd, and seemed cold not to give David the opportunity of a maiden speech.
The next thing the board did that day, after completing the A/EGM, was to formally invest David Allmond as CEO.
James stated that, last thing on the video.

It is also IMO a fact that those questions in the AGM that were asked as part of the Q&A session, were all pre-selected because after each answer provided by Graham, Jean-Pierre was reading from his notes, to translate the answer just provided.
Those notes were necessary to allow French shareholders to get the fullest possible translation, thus providing proof of question pre-selection.

++++
As long as one highly unlikely possibility remains of NCYT taking DHSC to court (or vice-versa), there can be no lifting of the silence for either party.
IMO the fact that Nick Plummer has resigned suggests to me:
1 David had already told him that he could leave.
2 The work Plummer had done and any choices or advice he provided did not satisfy BoD.
3 Plummer left to accept another position or consultancy, - but this will not be true without a LinkedIn update.
Anticipating with relish Nick Plummer's LinkedIn update. It currently states still in post at Novacyt.

*IF* Plummer was advised he could go, who else might be getting a similar message?

++++

It will be interesting to see if anybody else starts making video's for Novacyt vice Jack Taylor.

RBM Invest -
"I’m afraid we’re beyond market sector sentiment now. We stand alone and it is NCYT sentiment that will drive any SP change, not Covid stock sentiment."

Aren't we forgetting that it is the UK who has problems with rising spread of virus. (> 45K new infections / day).

From Reuters - https://graphics.reuters.com/world-coronavirus-tracker-and-maps/countries-and-territories/france/

"France is reporting 4,647 new infections on average each day, 9% of the peak — the highest daily average reported on November 7."

French shareholders will not necessarily have the same views about the amount of testing going on in France and Europe,
but can be assumed to know the UK situation.

Is there anyone who can state when the company should be in receipt of the £17Mil tax overpayments please?

Plummer, Mullis and Dyer joining forces? - Well that driving Taxis.

He possibly got bored. The DHSC dispute may have a finite date when all will be revealed with nothing to do in between.
Unless there is some M&A, there isn't enough to do.

FWIW Nick might have become a consultant, or started his own business with Novacyt as one of the first customers.
Nick was present on the Novacyt website yesterday morning, which suggests it's not Mandy's job to update it !

HereKittyKitty -
"This will move suddenly"
Your list does not contain the fact that there are only 70.6 million shares in issue, which places this item high in the list.

If this is what point of care testing looks like in USA, then Guillermo and Kevin's sales efforts will be fruitful.

https://talisbio.com/talis-one-point-of-care-instrument/

NIH:
Interferon does not improve outcomes for hospitalized adults with COVID-19.

This RNS is exactly the response required to the above news.

https://www.theguardian.com/world/2021/oct/19/fears-grow-in-england-over-rise-of-new-covid-delta-variant

A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta.

According to a briefing from the UK Health Security Agency, released on Friday, “a Delta sublineage newly designated as AY.4.2 is noted to be expanding in England”, with the body adding that the variant is being monitored and assessed.

The report states that in the week beginning 27 September – the last week for which complete sequencing data was available – AY.4.2 accounted for about 6% of sequenced coronavirus cases and is “on an increasing trajectory”.

+++

So NCYT are on to it and I hope to see an SNP-sig assay soon.
At least we know what Ajan Reginald is up to presently.

Kevin Crittenton busy taking orders this week? - I think so.

"The Company is pleased to report that all resolutions proposed to the shareholders were duly passed. "

Oh, and as an after thought, we changed our CEO, - thought you'd like to know.

DRB -

Start point is Kaeren's link https://twitter.com/NovacytGroup/status/1449370306737475590?s=20

"So HT with results in under 3 hours."
The 3 hours I assume comes from the statement on this web page:

bit.ly/3puuV95 = https://www.genesig.com/products/10061-genesig-covid-19-3g .
Excerpt follows:
Key Features:

. High priming efficiency
. Accurate controls to confirm extraction and assay validity
. Lyophilised components for ambient shipping
. ***Results in under 3 hours***
. Multi-platform capability

This web page is for the NON HT 3g product - genesig COVID-19 3G - Catalogue no: D00063 .

At the bottom of the page :

Purchase options

genesig COVID-19 3G
Catalogue no: D00063

genesig COVID-19 3G HT Assay
Catalogue no: D00062

If you click on resources, you will get the option to download COVID-19 3 gene HT Assay IFU,
Catalogue no: D00062 -
available at https://www.genesig.com/assets/files/path_covid_19_3g_ht_ce_sted_ifu_issue_2_00_1.pdf

This is the file that should be searched for a HT process time, and no process time is available (AFAI can see).

Just trying to rectify things without introducing too much complexity, - but difficult.

Agree something seems amiss EXMEX.
Suggest sending these concerns to Nick Plummer, General Counsel and Company Secretary at Novacyt Group

Nick.Plummer@